Name | (4E)-3-Hydroxy-2-(palmitoylamino)-4-octadecen-1-yl 2-methoxyethyl succinate |
---|---|
Synonyms |
(4E)-3-Hydroxy-2-(palmitoylamino)-4-octadecen-1-yl 2-methoxyethyl succinate
Butanedioic acid, (4E)-3-hydroxy-2-[(1-oxohexadecyl)amino]-4-octadecen-1-yl 2-methoxyethyl ester |
Description | C16 PEG-Ceramide is a polyethylene glycolylated ceramide. C16 PEG-Ceramide can be used for lipid carrier to delivery. C16 PEG-Ceramide induces autophagy. C16 PEG-Ceramide can be used for cancer research[1][2]. |
---|---|
Related Catalog | |
In Vitro | C16 PEG-Ceramide (0-118.6μM, 24 hours) has cytotoxicity and promotes autophagy in N2a cells[2]. Cell Cytotoxicity Assay[2]. Cell Line: N2a cells Concentration: 3.7-118.6 μM Incubation Time: 24 hours Result: Inhibits N2a cells activity in a dose-dependent. Western Blot Analysis[2]. Cell Line: N2a cells Concentration: 2.5, 5.0, 10 and 20 μM Incubation Time: 24 hours Result: Increased the LC3-II/LC3-I ratios, reduced the content of WT-Tau and P301L-Tau proteins in the cells. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 753.6±60.0 °C at 760 mmHg |
Molecular Formula | C41H77NO7 |
Molecular Weight | 696.053 |
Flash Point | 409.6±32.9 °C |
Exact Mass | 695.570007 |
LogP | 13.58 |
Vapour Pressure | 0.0±5.7 mmHg at 25°C |
Index of Refraction | 1.477 |
Storage condition | 2-8°C |